Excitatory amino acid receptor antagonists: a novel treatment for ischemic cerebrovascular diseases.
Scatton
B
B
Synthélabo Recherche, Preclinical Research Department, Bagneux, France.
D000818:Animals; D002545:Brain Ischemia / Q000188:drug therapy* / Q000378:metabolism; D016291:Dizocilpine Maleate / Q000627:therapeutic use; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D010875:Pipecolic Acids / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D018091:Receptors, AMPA / Q000037:antagonists & inhibitors; D018092:Kainic Acid Receptors / Q000037:antagonists & inhibitors; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors
D016291:Dizocilpine Maleate; D018691:Excitatory Amino Acid Antagonists; D010875:Pipecolic Acids; D010880:Piperidines; D018091:Receptors, AMPA; D018092:Kainic Acid Receptors; D016194:Receptors, N-Methyl-D-Aspartate; C053672:selfotel; C058083:eliprodil